Clinical Trial Update: Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant [NA]

View source ↗

Summary

Results from a completed clinical trial evaluating the use of aprepitant to prevent nausea and vomiting in cancer patients undergoing stem cell transplantation.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Cancer | NA | Status: COMPLETED | Results posted: 2011-12-21